Studies indicate that patients with ITCLD-GT should be treated conservatively. Chemotherapy regimens directed at malignant lymphoma and treatment regimens used to treat celiac disease, Crohn's disease, or ulcerative colitis have had little or no beneficial effects on the course of the disease. Patients should be follow regularly with peripheral blood and bone marrow examinations, GI<unk>  endoscopic examinations and PET scans in order to detect the progression of ITCLD-GT to a malignant phase.
Indolent T cell lymphoproliferative disorder of the gastrointestinal tract
Foreign body in alimentary tract
Effects of parasitic worms on the immune system
Small intestine neuroendocrine tumor
Autoimmune gastrointestinal dysmotility
Multifocal stenosing ulceration of the small intestine
Gastric antral vascular ectasia
Cystic lesions of the pancreas